Current Topics in Lung Cancer

1. Front Matter

   Pages i-vii

   PDF

2. Introduction

   • Paul A. Bunn Jr.

   Pages 1-1

3. The Biology of Lung Cancer

   • Desmond N. Carney

   Pages 3-14

4. Staging and Surgical Treatment for Non-Small Cell Lung Cancer

   • Robert J. Ginsberg

   Pages 15-24

5. Radiotherapy for Non-Small Cell Lung Cancer

   • Andrew T. Turrisi III

   Pages 25-31

6. The Role of Systemic Chemotherapy in Non-Small Cell Lung Cancer

   • Paul A. Bunn Jr.

   Pages 33-46

7. Staging and Treatment for Small Cell Lung Cancer

   • Pieter E. Postmus

   Pages 47-60

8. Surgery for Small Cell Lung Cancer

   • Robert J. Ginsberg

   Pages 61-62

9. Combined Modality Therapy for Limited Small Cell Lung Cancer

   • Andrew T. Turrisi III

   Pages 63-66

10. Cranial Irradiation

    • Andrew T. Turrisi III

    Pages 67-69

11. Future Directions in the Therapy of Lung Cancer

    • James F. Bishop

    Pages 71-82

12. Back Matter

    Pages 83-84

    PDF

The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer­ sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of oncology.

• Chemotherapie
• Chirurgie
• Radiotherapie
• Radiotherapy
• Staging
• diagnosis
• surgery
• thoracic surgery

• University of Colorado Cancer Center, Denver, USA

  Paul A. Bunn

Policies and ethics